Related Experiment Video
Updated: Jun 10, 2026
08:30
Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
Post-TIPS Dynamics of von Willebrand Factor for Risk Stratification After TIPS Placement
Marlene Hintersteininger1,2,3, Simon Johannes Gairing4, Katrin Kirsch4
1Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Summary
A decrease in von Willebrand factor antigen (VWF) after transjugular intrahepatic portosystemic shunt (TIPS) placement indicates a favorable prognosis. Combining VWF dynamics with interleukin-6 (IL6) response improves mortality risk stratification in patients undergoing TIPS.
Area of Science:
- Hepatology
- Vascular Surgery
- Biomarker Research
Background:
- Transjugular intrahepatic portosystemic shunt (TIPS) is a key intervention for managing portal hypertension complications.
- Prognostic markers are crucial for optimizing patient management post-TIPS.
Purpose of the Study:
- To investigate the prognostic significance of von Willebrand factor antigen (VWF) dynamics following TIPS placement.
- To assess the combined predictive value of VWF and interleukin-6 (IL6) response for patient outcomes.
Main Methods:
- A combined longitudinal cohort (CLC) was established from patients undergoing TIPS at two medical centers.
- VWF levels at baseline and 3 months post-TIPS were analyzed, defining VWF-Response as a ≥5% decrease.
- Patients were stratified into risk groups (R2, R1, R0) based on VWF and IL6 response patterns.
Main Results:
- VWF levels significantly decreased 3 months post-TIPS (median 313.0% to 262.0%, p=0.007).
- VWF change and achieving VWF-Response were independently associated with improved survival (asHR: 2.75 and 0.24, respectively).
- Risk stratification using VWF and IL6 responses showed distinct 2-year cumulative incidences of death: R2 (10.6%), R1 (23.1%), and R0 (46.7%).
Conclusions:
- VWF-Response following TIPS placement is a significant indicator of a favorable prognosis.
- The combination of VWF and IL6 response offers a robust tool for stratifying mortality risk in patients after TIPS.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...